Cytek Biosciences, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q4 2022 to Q1 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary: Cytek Biosciences, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q4 2022 to Q1 2025.
Cytek Biosciences, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending March 31, 2025 was $645K, a 3.04% increase year-over-year.

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2025	$645K	+$19K	+3.04%	Mar 31, 2025	10-Q	2025-05-08
Q4 2024	$559K	-$192K	-25.6%	Dec 31, 2024	10-K	2025-02-28
Q3 2024	$501K	-$333K	-39.9%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$606K	-$317K	-34.3%	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	$626K	-$389K	-38.3%	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$751K	-$361K	-32.5%	Dec 31, 2023	10-K	2024-03-13
Q3 2023	$834K			Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$923K			Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$1.02M			Mar 31, 2023	10-Q	2023-05-09
Q4 2022	$1.11M			Dec 31, 2022	10-K	2023-03-01

Showing 1 to 10 of 10 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.